| The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin (NCT02287415) | Bial - Portela C S.A. | 2002-05-01 |
| Functional Coupling of Cortico-Cortical and Cortico-Muscular Connections During Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control (NCT00036595) | National Institute of Neurological Disorders and Stroke (NINDS) | 2002-05-01 |
| A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093 (NCT02170077) | Bial - Portela C S.A. | 2002-04-01 |
| Study of an External Responsive Neurostimulator System on Epileptiform Activity (NCT00158067) | NeuroPace | 2002-03-01 |
| Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers (NCT01678976) | Bial - Portela C S.A. | 2002-03-01 |
| Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy (NCT00043914) | GlaxoSmithKline | 2002-01-14 |
| Multicenter Trial for Adults With Partial Seizures (NCT00034814) | Teva Branded Pharmaceutical Products R&D, Inc. | 2002-01-01 |
| RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy (NCT00564915) | Institute of Child Health | 2001-12-01 |
| Lamotrigine Pregnancy Registry (LAM05) (NCT01064297) | GlaxoSmithKline | 2001-11-01 |
| Study of Specimens Obtained During Epilepsy Surgery (NCT00025714) | National Institute of Neurological Disorders and Stroke (NINDS) | 2001-10-10 |
| Observational Study of Lamotrigine (NCT00299793) | Northwell Health | 2001-10-01 |
| The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093 (NCT02170649) | Bial - Portela C S.A. | 2001-09-01 |
| Depression and Health Outcomes in Refractory Epilepsy (NCT00026637) | Columbia University | 2001-08-01 |
| PET Study of the Nicotinic Receptors in Human (NCT00543322) | Commissariat A L'energie Atomique | 2001-07-01 |
| Evaluation and Treatment of Patients With Epilepsy (NCT00013845) | National Institute of Neurological Disorders and Stroke (NINDS) | 2001-05-01 |
| A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093 (NCT02171234) | Bial - Portela C S.A. | 2001-02-01 |
| Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method (NCT00600509) | UCB Pharma | 2001-01-01 |
| Clinical Applications of High-Frequency Oscillations (NCT00600717) | Children's Hospital Medical Center, Cincinnati | 2000-11-01 |
| Progesterone vs Placebo Therapy for Women With Epilepsy (NCT00029536) | Beth Israel Deaconess Medical Center | 2000-10-01 |
| Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy (NCT00021866) | Emory University | 2000-09-01 |
| Pediatric Epilepsy Study in Subjects 1-24 Months (NCT00044278) | GlaxoSmithKline | 2000-09-01 |
| S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy (NCT00630968) | UCB Pharma | 2000-08-01 |
| A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093 (NCT02171195) | Bial - Portela C S.A. | 2000-07-01 |
| Brain Infusion of Muscimol to Treat Epilepsy (NCT00005925) | National Institute of Neurological Disorders and Stroke (NINDS) | 2000-06-23 |
| Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis (NCT00004403) | Johns Hopkins University | 2000-05-01 |
| Pediatric Epilepsy Trial in Subjects 1-24 Months (NCT00043875) | GlaxoSmithKline | 2000-05-01 |
| Exploring the Comorbidity Between Mental Disorders and General Medical Conditions (NCT03847753) | University of Aarhus | 2000-01-01 |
| Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy (NCT00179426) | Beth Israel Deaconess Medical Center | 1999-10-01 |
| Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures (NCT00615615) | UCB Pharma | 1999-09-01 |
| A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy (NCT00231556) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1999-07-01 |
| Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study (NCT00041951) | Icahn School of Medicine at Mount Sinai | 1998-12-01 |
| Developing Criteria for Cortical Resections (NCT00152659) | University of Chicago | 1998-09-01 |
| Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients (NCT00236886) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1998-05-01 |
| A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy (NCT00236717) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1997-09-01 |
| Ketogenic Diet for Child Epilepsy and Seizure Control (NCT00004729) | National Institute of Neurological Disorders and Stroke (NINDS) | 1997-07-01 |
| Genetic Study of Familial Epilepsy (NCT00006059) | National Center for Research Resources (NCRR) | 1997-01-01 |
| Infrared Camera for Brain Mapping During Surgery (NCT00001554) | National Institute of Neurological Disorders and Stroke (NINDS) | 1996-06-01 |
| Human Epilepsy Genetics--Neuronal Migration Disorders Study (NCT00041600) | Harvard University Faculty of Medicine | 1996-04-01 |
| A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure (NCT00230698) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1995-11-01 |
| A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures (NCT00236418) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1994-12-01 |
| Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism (NCT00001489) | National Institute of Neurological Disorders and Stroke (NINDS) | 1994-10-01 |
| A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy (NCT00236743) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1994-06-01 |
| A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures (NCT00236704) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1994-03-01 |
| Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment (NCT00004758) | National Center for Research Resources (NCRR) | 1993-11-01 |
| A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome (NCT00236756) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1993-08-01 |
| Brain Blood Flow Studies of Language and Memory (NCT00001288) | National Institute of Neurological Disorders and Stroke (NINDS) | 1991-05-01 |
| A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. (NCT00236847) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1989-12-01 |
| A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. (NCT00236873) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1989-10-01 |
| A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures (NCT00236860) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1989-05-01 |
| A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. (NCT00236691) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1988-07-01 |
| A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy (NCT00236730) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1988-06-01 |
| Monitoring Patients With Uncontrolled Epilepsy (NCT00001149) | National Institute of Neurological Disorders and Stroke (NINDS) | 1975-11-01 |
| Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy (NCT02660255) | University of Nebraska | |
| Treatment of Drug Resistant Epilepsy (NCT02461706) | University of Florida | |
| Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits (NCT00851331) | University Hospital, Strasbourg, France | |
| Compassionate Use Program With Brivaracetam for the Treatment of Patients With Epilepsy (NCT03532516) | UCB Biopharma SRL | |
| Hormone Replacement in Menopausal Women With Epilepsy (NCT00027209) | National Institute of Neurological Disorders and Stroke (NINDS) | |
| Double-Blind, Placebo-Controlled Trial of Vitamin E as Add-on Therapy for Children With Epilepsy (NCT00004637) | National Center for Research Resources (NCRR) | |
| Prediction of Childhood Epilepsy Outcome in Bangladesh (NCT00381537) | Institute of Child Health | |
| Pediatric Epilepsy Database (NCT00204360) | University of Alabama at Birmingham | |